Analyst Ratings published Wednesday February 12th 2025

2/12/25	Downgrades	Outperform Mkt Perform	X
ACLS Axcelis Tech William Blair
2/12/25	Initiated	Overweight	X
AZN AstraZeneca Morgan Stanley
2/12/25	Downgrades	Buy Sell	X
BBD Banco Bradesco Goldman
$2.40 $2
2/12/25	Downgrades	Outperform Mkt Perform	X
BCML BayCom Hovde Group
$31
2/12/25	Upgrades	Sell Neutral	X
BSBR Banco Santander Brasil Goldman
$4.20 $4.70
2/12/25	Initiated	Buy	X
CART Instacart Seaport Research Partners
$62
2/12/25	Initiated	Buy	X
CLSK CleanSpark Needham
$20
2/12/25	Upgrades	Neutral Overweight	X
CMP Compass Minerals JP Morgan
$13 $15
2/12/25	Upgrades	Sell Hold	X
CRSP CRISPR Therapeutics TD Cowen
$35
2/12/25	Upgrades	Neutral Overweight	X
CVS CVS Health Cantor Fitzgerald
2/12/25	Upgrades	Mkt Perform Outperform	X
CXW CoreCivic Noble Capital Markets
2/12/25	Upgrades	Negative Positive	X
DELL Dell OTR Global
2/12/25	Downgrades	Neutral Sell	X
EDR Endeavor Group Seaport Research Partners
$27.50
2/12/25	Resumed	Neutral	X
EIX Edison JP Morgan
2/12/25	Upgrades	Sec Perform Outperform	X
EOG EOG Resources RBC Capital Mkts
$150 $155
2/12/25	Initiated	Overweight	X
EPRT Essential Properties Realty Trust CapitalOne
$35
2/12/25	Upgrades	Hold Buy	X
ERO Ero Copper TD Cowen
2/12/25	Downgrades	Positive Neutral	X
FIS Fidelity Nat’l Info Susquehanna
$103 $81
2/12/25	Downgrades	Outperform Sec Perform	X
FLNC Fluence RBC Capital Mkts
$25 $7
2/12/25	Downgrades	Buy Neutral	X
FLNC Fluence ROTH MKM
$20 $6.50
2/12/25	Downgrades	Buy Neutral	X
FLNC Fluence UBS
$28 $8
2/12/25	Downgrades	Outperform Peer Perform	X
FLNC Fluence Wolfe Research
2/12/25	Upgrades	Hold Buy	X
GFS GlobalFoundries Needham
$50
2/12/25	Resumed	Overweight	X
GRFS Grifols, S.A. Morgan Stanley
2/12/25	Initiated	Equal-Weight	X
GSK GlaxoSmithKline Morgan Stanley
2/12/25	Initiated	Buy	X
LCID Lucid Group The Benchmark Company
$5
2/12/25	Upgrades	Mkt Perform Mkt Outperform	X
LCII LCI Industries CJS Securities
$145
2/12/25	Downgrades	Buy Hold	X
MBRX Moleculin Biotech Maxim Group
2/12/25	Upgrades	Outperform Strong Buy	X
MCY Mercury General Raymond James
$70 $80
2/12/25	Initiated	Buy	X
MYGN Myriad Genetics Craig Hallum
$29
2/12/25	Initiated	Overweight	X
NTST NETSTREIT CapitalOne
2/12/25	Initiated	Equal-Weight	X
NVO Novo Nordisk A/S Morgan Stanley
2/12/25	Initiated	Underweight	X
NVS Novartis AG Morgan Stanley
2/12/25	Upgrades	Eq-Weight Overweight	X
NXPI NXP Semi Morgan Stanley
$231 $257
2/12/25	Downgrades	Buy Neutral	X
ONON On Goldman
$57
2/12/25	Upgrades	Underperform Hold	X
PAC Grupo Aeroportuario del Pacifico Jefferies
$140 $210
2/12/25	Reiterated	Lame	X
PAPSX Paper Street Soap Company Jack Powers Capital
$9,669
2/12/25	Resumed	Overweight	X
PCG PG&E JP Morgan
2/12/25	Downgrades	Overweight Neutral	X
PPG PPG Industries JP Morgan
$145 $115
2/12/25	Initiated	Buy	X
RL Ralph Lauren Needham
$310
2/12/25	Initiated	Overweight	X
RPID Rapid Micro Biosystems KeyBanc Capital Markets
$8
2/12/25	Downgrades	Buy Neutral	X
STAA STAAR Surgical BTIG Research
2/12/25	Downgrades	Buy Hold	X
STAA STAAR Surgical Jefferies
2/12/25	Downgrades	Outperform Neutral	X
STAA STAAR Surgical Mizuho
$45 $17
2/12/25	Downgrades	Outperform Mkt Perform	X
STAA STAAR Surgical William Blair
2/12/25	Initiated	Buy	X
TGS Transportadora de Gas del Sur Citigroup
$35
2/12/25	Downgrades	Overweight Eq-Weight	X
THRD Third Harmonic Bio Morgan Stanley
$20 $5
2/12/25	Initiated	Buy	X
TSLA Tesla The Benchmark Company
$475
2/12/25	Initiated	Outperform	X
UEC Uranium Energy National Bank Financial
$10
2/12/25	Upgrades	Neutral Buy	X
UPST Upstart B. Riley Securities
$49 $105
2/12/25	Upgrades	Underweight Neutral	X
UPST Upstart JP Morgan
$57 $79
2/12/25	Initiated	Buy	X
VFC V.F. Corp Needham
$28
2/12/25	Initiated	Outperform	X
VLRS Volaris Aviation Itau BBA
$12
2/12/25	Upgrades	Sell Hold	X
VRTX Vertex Pharma Canaccord Genuity
$408 $424